Clinical trial
The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection
NCT06591494 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Phase
- Phase 2/3
- Overall status
- Not yet recruiting
- Start date
- September 15, 2024
- Completion date
- December 30, 2025
- Enrollment
- 855 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection